Replicating retroviral vectors for oncolytic virotherapy of experimental hepatocellular carcinoma

Oncology Reports

Volumn 28, Issue 1, 2012, Pages 21-26

  Lu, Yin Che ^a   Chen, Ying Ju ^b   Yu, Yuan Ren ^b   Lai, Yi Hui ^b   Cheng, Jen Chieh ^b   Li, Yu Fen ^c   Shen, Cheng Huang ^a,b   Tai, Chien Kuo ^b  

^a CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

^b NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cytosine deaminase; Hepatocellular carcinoma; Oncolytic virotherapy; Retrovirus

Indexed keywords

CYTOSINE DEAMINASE; FLUCYTOSINE; ONCOLYTIC VIRUS; REPLICATING RETROVIRUS VECTOR; RETROVIRUS VECTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER GENE THERAPY; CANCER INHIBITION; CELL KILLING; CELL POPULATION; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; GIBBON LEUKEMIA VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTERNAL RIBOSOME ENTRY SITE; INTRACELLULAR SIGNALING; LIVER CELL CARCINOMA; MOUSE; MULTIPLE CYCLE TREATMENT; MURINE LEUKEMIA VIRUS; NONHUMAN; ONCOLYTIC VIROTHERAPY; PRIORITY JOURNAL; SUICIDE GENE; SUICIDE GENE THERAPY; TREATMENT RESPONSE; TUMOR XENOGRAFT; VIRAL GENE DELIVERY SYSTEM; VIRUS REPLICATION;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOTRANSFORMATION; CARCINOMA, HEPATOCELLULAR; CELL SURVIVAL; CYTOSINE DEAMINASE; FLUCYTOSINE; FUNGAL PROTEINS; GENE THERAPY; HEP G2 CELLS; HUMANS; LEUKEMIA VIRUS, GIBBON APE; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, NUDE; ONCOLYTIC VIROTHERAPY; ONCOLYTIC VIRUSES; PRODRUGS; RECOMBINANT PROTEINS; TRANSDUCTION, GENETIC; TUMOR BURDEN; VIRUS REPLICATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84861562252     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1789     Document Type: Article

References (24)

1. Smerdou C, Menne S, Hernandez-Alcoceba R and Gonzalez-Aseguinolaza G: Gene therapy for HCV/HBV-induced hepatocellular carcinoma. Curr Opin Investig Drugs 11: 1368-1377, 2010.
2. Fukazawa T, Matsuoka J, Yamatsuji T, Maeda Y, Durbin ML and Naomoto Y: Adenovirus-mediated cancer gene therapy and virotherapy (Review). Int J Mol Med 25: 3-10, 2010.
3. Kirn D, Martuza RL and Zwiebel J: Replication-selective viro-therapy for cancer: biological principles, risk management and future directions. Nat Med 7: 781-787, 2001. (Pubitemid 32691631)
4. Tai CK and Kasahara N: Replication-competent retrovirus vectors for cancer gene therapy. Front Biosci 13: 3083-3095, 2008.
5. Lewis PF and Emerman M: Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J Virol 68: 510-516, 1994.
6. Miller DG, Adam MA and Miller AD: Gene transfer by retro-virus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 10: 4239-4242, 1990.
7. Varmus HE, Padgett T, Heasley S, Simon G and Bishop JM: Cellular functions are required for the synthesis and integration of avian sarcoma virus-specific DNA. Cell 11: 307-319, 1977. (Pubitemid 8150692)
8. Wang WJ, Tai CK, Kasahara N and Chen TC: Highly efficient and tumor-restricted gene transfer to malignant gliomas by replication-competent retroviral vectors. Hum Gene Ther 14: 117-127, 2003. (Pubitemid 36418816)
9. Tai CK, Wang WJ, Chen TC and Kasahara N: Single-shot, multi-cycle suicide gene therapy by replication-competent retrovirus vectors achieves long-term survival benefit in experimental glioma. Mol Ther 12: 842-851, 2005. (Pubitemid 41614479)
10. Tai CK, Wang W, Lai YH, et al: Enhanced efficiency of prodrug activation therapy by tumor-selective replicating retrovirus vectors armed with the Escherichia coli purine nucleoside phosphorylase gene. Cancer Gene Ther 17: 614-623, 2010.
11. Lu YC, Luo YP, Wang YW and Tai CK: Highly efficient gene transfer to solid tumors in vivo by tumor-selective replicating retrovirus vectors. Int J Mol Med 25: 769-775, 2010.
12. Kievit E, Bershad E, Ng E, et al: Superiority of yeast over bacterial cytosine deaminase for enzyme/prodrug gene therapy in colon cancer xenografts. Cancer Res 59: 1417-1421, 1999. (Pubitemid 29160102)
13. Kievit E, Nyati MK, Ng E, et al: Yeast cytosine deaminase improves radiosensitization and bystander effect by 5-fluorocytosine of human colorectal cancer xenografts. Cancer Res 60: 6649-6655, 2000.
14. Nakamura H, Mullen JT, Chandrasekhar S, Pawlik TM, Yoon SS and Tanabe KK: Multimodality therapy with a replication-conditional herpes simplex virus 1 mutant that expresses yeast cytosine deaminase for intratumoral conversion of 5-fluorocytosine to 5-fluorouracil. Cancer Res 61: 5447-5452, 2001. (Pubitemid 32694925)
15. Logg CR, Logg A, Matusik RJ, Bochner BH and Kasahara N: Tissue-specific transcriptional targeting of a replication-competent retroviral vector. J Virol 76: 12783-12791, 2002. (Pubitemid 35386962)
16. Pear WS, Nolan GP, Scott ML and Baltimore D: Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA 90: 8392-8396, 1993. (Pubitemid 23277674)
17. Tai CK, Logg CR, Park JM, Anderson WF, Press MF and Kasahara N: Antibody-mediated targeting of replication-competent retroviral vectors. Hum Gene Ther 14: 789-802, 2003. (Pubitemid 36623515)
18. Hiraoka K, Kimura T, Logg CR, et al: Therapeutic efficacy of replication-competent retrovirus vector-mediated suicide gene therapy in a multifocal colorectal cancer metastasis model. Cancer Res 67: 5345-5353, 2007. (Pubitemid 46997274)
19. Andreadis ST, Roth CM, Le Doux JM, Morgan JR and Yarmush ML: Large-scale processing of recombinant retroviruses for gene therapy. Biotechnol Prog 15: 1-11, 1999. (Pubitemid 29087582)
20. Gordon EM and Hall FL: The 'timely' development of Rexin-G: First targeted injectable gene vector (Review). Int J Oncol 35: 229-238, 2009.
21. Rainov NG: A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Hum Gene Ther 11: 2389-2401, 2000.
22. Metzl C, Mischek D, Salmons B, Gunzburg WH, Renner M and Portsmouth D: Tissue- and tumor-specific targeting of murine leukemia virus-based replication-competent retroviral vectors. J Virol 80: 7070-7078, 2006. (Pubitemid 44025204)
23. Overbaugh J, Miller AD and Eiden MV: Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins. Microbiol Mol Biol Rev 65: 371-389, 2001. (Pubitemid 32881711)
24. Yue QH, Hu XB, Yin Y, et al: Inhibition of prostate cancer by suicide gene targeting the FCY1 and HSV-TK genes. Oncol Rep 22: 1341-1347, 2009.